# OnCo record skin-and-nail-care-during-cancer-drug-treatment (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/skin-and-nail-care-during-cancer-drug-treatment/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "skin-and-nail-care-during-cancer-drug-treatment" ;
  schema:name "Skin and nail care during chemotherapy and targeted therapy"@en ;
  schema:alternateName "skin care on chemotherapy"@en, "EGFR inhibitor rash care"@en, "acneiform rash prevention"@en, "paronychia prevention"@en, "hand-foot syndrome skin care"@en, "nail care during chemotherapy"@en, "dry skin on targeted therapy"@en ;
  schema:description "Many cancer drugs dry the skin; some cause an acne-like rash, sore nail folds or red, painful hands and feet. Gentle washing in lukewarm water, a thick fragrance-free moisturiser, gloves for housework and careful nail trimming help; with some targeted drugs the team prescribes preventive creams from day one. Tell the team early about a rash or sore nails, and urgently about a rash with wheezing."@en ;
  schema:url <https://onco.cc/protocols/skin-and-nail-care-during-cancer-drug-treatment/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:related <https://onco.cc/protocols/sun-protection-during-and-after-cancer-treatment/> ;
  onco:drugs <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/panitumumab/>, <https://onco.cc/drugs/erlotinib/>, <https://onco.cc/drugs/gefitinib/>, <https://onco.cc/drugs/afatinib/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/fluorouracil/> ;
  onco:terms <https://onco.cc/terms/hand-foot-syndrome/>, <https://onco.cc/terms/rash-skin-toxicity/> .